An adaptive trial design to optimize dose‐schedule regimes with delayed outcomes
From MaRDI portal
Publication:5128802
DOI10.1111/biom.13116zbMath1451.62129OpenAlexW2955527447WikidataQ91625934 ScholiaQ91625934MaRDI QIDQ5128802
Peter F. Thall, Ruitao Lin, Ying Yuan
Publication date: 26 October 2020
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1111/biom.13116
missing dataBayesian designoptimal treatment regimeadaptive randomizationphase I-II clinical trialordered subgroups
Applications of statistics to biology and medical sciences; meta analysis (62P10) Response surface designs (62K20) Missing data (62D10)
Related Items (1)
This page was built for publication: An adaptive trial design to optimize dose‐schedule regimes with delayed outcomes